Search in:

OncoTargets and Therapy Volume 10, 2017 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Fangbin Song1 Department of General Surgery

Jianbing Zhang2 Department of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

Shanbao Li1 Department of General Surgery

Junyi Wu1 Department of General Surgery

Tao Jin1 Department of General Surgery

Jun Qin1 Department of General Surgery

Ye Wang1 Department of General Surgery

Min Wang1 Department of General Surgery

Junming Xu1 Department of General SurgeryCorrespondence[email protected]

show all

Pages 4859-4867 | Published online: 03 Oct 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno, Tomoko Sugihara, Zhanglin Lin Cui & Kimberley T Lee. (2022) A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer. Future Oncology 18:21, pages 2667-2682.
Crossref

Yan Wisnu Prajoko, Rizka Hastari, Muflihatul Muniroh & Dik Puspasari. (2022) Expression of Stanniocalcin-1 as a Predictor of Recurrence in Breast Cancer Patients. Open Access Macedonian Journal of Medical Sciences 10:B, pages 346-350.
Crossref

Bin Cai, James Simon, Paola Villa, Nicoletta Biglia, Nicholas Panay, Stora Djumaeva, Martire Particco, Hemanth Kanakamedala & Corrado Altomare. (2020) No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA). Maturitas 142, pages 38-44.
Crossref

Seung Taek Lim, Ye Won Jeon, Hongki Gwak & Young Jin Suh. (2020) Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer. Journal of Breast Cancer 23:5, pages 498.
Crossref

Claire Buchta Rosean, Raegan R. Bostic, Joshua C.M. Ferey, Tzu-Yu Feng, Francesca N. Azar, Kenneth S. Tung, Mikhail G. Dozmorov, Ekaterina Smirnova, Paula D. Bos & Melanie R. Rutkowski. (2019) Preexisting Commensal Dysbiosis Is a Host-Intrinsic Regulator of Tissue Inflammation and Tumor Cell Dissemination in Hormone Receptor–Positive Breast Cancer. Cancer Research 79:14, pages 3662-3675.
Crossref

Xiao‐Han Jin, Yong‐Sheng Jia, Ye‐Hui Shi, Qiu‐Ying Li, Shi‐Qi Bao, Wen‐Ping Lu & Zhong‐Sheng Tong. (2018) ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF‐κB activation. Journal of Cellular Biochemistry 120:2, pages 1386-1397.
Crossref

Li Li, Bingmei Chang, Xiaoyue Jiang, Xueke Fan, Yingrui Li, Teng Li, Shanshan Wu, Jun Zhang, Seyed Kariminia & Qin Li. (2018) Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer. BMC Cancer 18:1.
Crossref

Xuelian Chen, Ying Fan & Binghe Xu. (2018) Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years. Clinical Breast Cancer 18:6, pages e1353-e1360.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Citations (8)

Articles from other publishers (8)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date